Targeting Oxidative Stress as a Therapeutic Approach for Idiopathic Pulmonary Fibrosis
Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial lung disease characterized by an abnormal reepithelialisation, an excessive tissue remodelling and a progressive fibrosis within the alveolar wall that are not due to infection or cancer. Oxidative stress has been proposed as a key molecu...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Book |
| Published: |
Frontiers Media S.A.,
2022-01-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_ee0f8c703ba8463287d0bf6d82e54d4a | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Cristina Estornut |e author |
| 700 | 1 | 0 | |a Javier Milara |e author |
| 700 | 1 | 0 | |a Javier Milara |e author |
| 700 | 1 | 0 | |a Javier Milara |e author |
| 700 | 1 | 0 | |a María Amparo Bayarri |e author |
| 700 | 1 | 0 | |a Nada Belhadj |e author |
| 700 | 1 | 0 | |a Julio Cortijo |e author |
| 700 | 1 | 0 | |a Julio Cortijo |e author |
| 700 | 1 | 0 | |a Julio Cortijo |e author |
| 700 | 1 | 0 | |a Julio Cortijo |e author |
| 245 | 0 | 0 | |a Targeting Oxidative Stress as a Therapeutic Approach for Idiopathic Pulmonary Fibrosis |
| 260 | |b Frontiers Media S.A., |c 2022-01-01T00:00:00Z. | ||
| 500 | |a 1663-9812 | ||
| 500 | |a 10.3389/fphar.2021.794997 | ||
| 520 | |a Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial lung disease characterized by an abnormal reepithelialisation, an excessive tissue remodelling and a progressive fibrosis within the alveolar wall that are not due to infection or cancer. Oxidative stress has been proposed as a key molecular process in pulmonary fibrosis development and different components of the redox system are altered in the cellular actors participating in lung fibrosis. To this respect, several activators of the antioxidant machinery and inhibitors of the oxidant species and pathways have been assayed in preclinical in vitro and in vivo models and in different clinical trials. This review discusses the role of oxidative stress in the development and progression of IPF and its underlying mechanisms as well as the evidence of oxidative stress in human IPF. Finally, we analyze the mechanism of action, the efficacy and the current status of different drugs developed to inhibit the oxidative stress as anti-fibrotic therapy in IPF. | ||
| 546 | |a EN | ||
| 690 | |a IPF-idiopathic pulmonary fibrosis | ||
| 690 | |a fibrosis | ||
| 690 | |a oxidative stress | ||
| 690 | |a ROS-reactive oxygen species | ||
| 690 | |a antioxidant therapy | ||
| 690 | |a Therapeutics. Pharmacology | ||
| 690 | |a RM1-950 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Frontiers in Pharmacology, Vol 12 (2022) | |
| 787 | 0 | |n https://www.frontiersin.org/articles/10.3389/fphar.2021.794997/full | |
| 787 | 0 | |n https://doaj.org/toc/1663-9812 | |
| 856 | 4 | 1 | |u https://doaj.org/article/ee0f8c703ba8463287d0bf6d82e54d4a |z Connect to this object online. |